Skip to main content
KROMEK GROUP PLC logo

KROMEK GROUP PLC — Investor Relations & Filings

Ticker · KMK ISIN · GB00BD7V5D43 LEI · 213800VLHYXGHEX5VQ48 IL Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2017-06-28 Earnings Release
Country GB United Kingdom
Listing IL KMK

About KROMEK GROUP PLC

https://www.kromek.com/

Kromek Group plc is a developer and manufacturer of advanced radiation detection solutions based on high-performance sensor materials, primarily Cadmium Zinc Telluride (CZT) and scintillation detectors. The company provides hardware, software, and components to original equipment manufacturers (OEMs) and end-users across the advanced imaging, civil nuclear, and security markets. Key applications include medical imaging systems (such as SPECT and photon-counting CT), industrial inspection, and CBRN (Chemical, Biological, Radiological, Nuclear) threat detection for homeland security, military, and civil nuclear sectors. The company's proprietary CZT manufacturing process enables the production of high-resolution, room-temperature semiconductor detectors that offer enhanced sensitivity and performance for imaging and radionuclide identification.

Recent filings

Filing Released Lang Actions
Final Results
Earnings Release Classification · 100% confidence The document explicitly states it contains the "Final Results for the Year ended 30 April 2017" for Kromek Group plc. It includes detailed financial highlights, operational highlights, a CEO statement, and a comprehensive financial review with tables comparing current year results to the previous year (2015/16). The content is characteristic of a full annual financial report, which aligns with the definition of a 10-K (Annual Report), even though it is presented via an RNS announcement format. Since the document contains the full audited results and comprehensive review, it is classified as the Annual Report (10-K) rather than just an Earnings Release (ER) or a Report Publication Announcement (RPA). The length (over 120,000 characters) also supports this being the full report content. FY 2017
2017-06-28 English
Kromek Radiation Detectors Used During Trump Visit
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and a date, indicating it is a regulatory announcement. The content describes a specific operational event: the deployment and successful use of the company's radiation detectors by the European Commission Counter Terrorism Unit during a high-profile visit. This is a piece of news or operational update that does not fit the specific definitions for financial reports (10-K, IR, ER), management changes (MANG), or shareholder actions (DIV, DVA). Since it is a general announcement released via the RNS system and doesn't fit a more specific category like Director's Dealing (DIRS) or Capital Change (CAP), it defaults to the general regulatory filing category, RNS, which serves as a miscellaneous regulatory announcement fallback.
2017-06-12 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is an official notification identified by the 'RNS Number' header. The content explicitly states the 'Total Voting Rights' as of a specific date (1 June 2017) and confirms the total number of issued ordinary shares, which is required information under FCA Disclosure and Transparency Rules. This type of announcement, detailing the denominator for shareholder interest notifications, is a specific regulatory disclosure. While it relates to share capital, it is not a general share issue (SHA) or a transaction in own shares (POS). It is a mandatory disclosure related to voting rights, which fits best under the general 'Regulatory Filings' (RNS) category as a specific regulatory update, or potentially DVA if it were voting results, but here it is about the total count. Given the structure and RNS source, RNS is the most appropriate general regulatory filing code, although it is very close to a share capital update. However, since it is a mandatory disclosure about the total number of voting rights, and not a transaction or a change in structure, RNS serves as the best fit among the provided options for a routine regulatory update.
2017-06-01 English
Holding(s) in Company
Director's Dealing Classification · 98% confidence The document is clearly identified by the header 'RNS Number : 9069D' and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content details a 'TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES', which reports a change in shareholding that crosses a notification threshold (falling below 4%). This type of mandatory disclosure regarding significant changes in ownership is a specific regulatory filing. While it relates to shareholding, the primary classification for mandatory regulatory disclosures that don't fit other specific categories (like 10-K, ER, or DIRS) is RNS. It is not a Director's Dealing (DIRS) as it concerns a major shareholder/client group (Killik & Co LLP/Platform Securities), nor is it a general share issue (SHA) or buyback (POS). Therefore, RNS is the most appropriate general regulatory filing code.
2017-05-02 English
Trading Update
Regulatory Filings Classification · 98% confidence The document is very short (1517 characters) and provides a brief 'Trading Update' for the year ending April 30, 2017, stating the company is 'trading in line with market expectations' and mentioning that full year results will be issued in July 2017. It is an announcement about current trading status rather than the full financial report itself. The document is explicitly marked with an 'RNS Number' and ends with 'This information is provided by RNS'. This structure strongly suggests it is a regulatory announcement intended for immediate release, fitting the definition of a general regulatory filing or an Earnings Release (ER) if it contained key figures. Since it is a high-level trading update ahead of the formal results, and given the explicit RNS tagging, it fits best as a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if it were more focused on preliminary numbers. Given the context of providing an update ahead of the full results, and the RNS source, RNS is a strong candidate, but ER is also plausible for a trading update. However, since it is a general update and not the formal release of period results, and it is explicitly sourced from RNS, I will classify it as RNS, which serves as the general regulatory announcement category.
2017-04-28 English
Block listing Interim Review
Capital/Financing Update Classification · 99% confidence The document is identified by the 'RNS Number : 6813B' header, indicating it is a Regulatory News Service announcement. The content details an 'Interim Review' for a 'Block Listing' under AIM Rules, specifically reporting on the balance of unallotted securities under an EMI Scheme for the period from September 30, 2016, to March 31, 2017. This type of specific, periodic regulatory update regarding share schemes and listing compliance, distributed via RNS, does not fit neatly into the defined categories like 10-K, ER, or IR. Since it is a formal regulatory announcement that doesn't match a more specific code (like DIRS or SHA), the most appropriate fallback category is Regulatory Filings (RNS). The document length is short (1882 chars), but it contains the full required information rather than just announcing another report.
2017-04-05 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.